Log in to save to my catalogue

Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease

Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ba4f3c78d68b4d88bfcba266552743c4

Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease

About this item

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) are related to several acquired demyelinating syndromes in adults, but the therapeutic approach is currently unclear. We aimed to describe the response to different therapeutic strategies in adult patients with relapsing MOG-Ab-associated disease.
This is a retrospective study conducted in...

Alternative Titles

Full title

Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ba4f3c78d68b4d88bfcba266552743c4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ba4f3c78d68b4d88bfcba266552743c4

Other Identifiers

ISSN

1742-2094

E-ISSN

1742-2094

DOI

10.1186/s12974-019-1525-1

How to access this item